Juvenile bullous pemphigoid: the presentation and follow‐up of six cases
- 7 December 2009
- journal article
- case report
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 24 (1), 69-72
- https://doi.org/10.1111/j.1468-3083.2009.03264.x
Abstract
Juvenile bullous pemphigoid (JBP) is a very rare autoimmune blistering disease. Up to now, 81 cases have been published. To describe clinical, histopathological and immunopathological characteristics of our patients with JBP, their response to therapy and clinical course, and to show the rarity of JBP in our population. Retrospective study of all patients with JBP diagnosed from 1983 to the end of 2007. The patients were followed from 6 months to 24 years. An academic, teaching hospital - Pediatric Dermatology Unit of the Institute of Dermatovenereology, Clinical Center of Serbia, Belgrade. Six patients with JBP (4 girls and 2 boys) aged 2 to 17 years. The average age at onset of BP was 10 years. The diagnosis was confirmed by histopathological analysis and direct immunofluorescence test. The patients were treated with systemic and topical corticosteroids, and three patients received dapsone. The disease control was achieved after 2 weeks to 2.5 months of therapy. The treatment lasted from 2 weeks to 4.5 months, 1.8 months at the average. The period from the beginning of the disease to complete remission ranged from 1.5 month to 5 years, with a mean value of 14 months. In one boy, the parents interrupted the therapy, and the disease remitted spontaneously after 5 years. According to our experience, JBP can spontaneously remit within 5 years. JBP has a relatively indolent course and may be a self-limiting disease. The patients should not be over-treated in order to avoid side-effects of medication.Keywords
This publication has 20 references indexed in Scilit:
- Bullous pemphigoid in infancy: Clinical and epidemiologic characteristicsJournal of the American Academy of Dermatology, 2008
- Childhood Bullous Pemphigoid in Association with Hyperimmunoglobulin E SyndromePediatric Dermatology, 2008
- Infantile bullous pemphigoid treated with intravenous immunoglobulin therapyJournal of the American Academy of Dermatology, 2007
- Childhood bullous pemphigoid: a case report and 10‐year follow upInternational Journal of Dermatology, 2007
- Anti-p200 pemphigoid in a 17-year-old girl successfully treated with systemic corticosteroid and dapsoneBritish Journal of Dermatology, 2007
- Drug‐resistant bullous pemphigoid and inflammatory bowel disease in a pediatric case successfully treated by plasma exchange and extracorporeal photochemotherapyJournal of Clinical Apheresis, 2007
- Childhood Bullous PemphigoidThe American Journal of Dermatopathology, 2003
- Bullous Pemphigoid and Epidermolysis Bullosa Acquisita: Presentation, Prognosis, and Immunopathology in 11 ChildrenPediatric Dermatology, 1998
- Bullous pemphigoid and epidermolysis bullosa acquisita: presentation, prognosis, and immunopathology in 11 children.Pediatric Dermatology, 1998